欢迎访问《复旦学报(医学版)》官方网站,今天是 分享到:
依维莫司与阿昔替尼二线治疗转移性肾细胞癌(mRCC)的临床疗效及不良反应比较
赖鹏, 胡骁轶, 郭剑明
Comparison of the clinical efficacy and adverse reaction between everolimus and axitinib in metastatic renal cell carcinoma (mRCC) patients as the second-line treatment
LAI Peng, HU Xiao-yi, GUO Jian-ming
复旦学报(医学版) . 2020, (01): 37 -41 .  DOI: 10.3969/j.issn.1672-8467.2020.01.007